1-9 of 9
Ron Levy, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Activity of a Sting and a TLR9 Agonist As an “in Situ Therapeutic Vaccination” Against Lymphomas

Adrienne Sallets, PhD, Idit Sagiv Barfi, PhD, Ron Levy, MD
Journal: Blood
Blood (2016) 128 (22): 48.
https://doi.org/10.1182/blood.V128.22.48.48
Published: 2016
Journal Articles

Antigen Presentation Profiling Reveals T-Cell Recognition of Lymphoma Immunoglobulin Neoantigens

Michael Khodadoust, MD PhD, Niclas Olsson, PhD, Lisa Wagar, PhD, Binbin Chen, Keith Rawson, Chih Long Liu, David Steiner, MD PhD, Samhita Rao, MS, Lichao Zhang, PhD, Henning Stehr, PhD, Aaron M Newman, PhD, Debra K Czerwinski, Victoria Carlton, PhD, Martin Moorhead, PhD, Malek Faham, MD PhD, Holbrook Kohrt, MD, Michael R Green, PhD, Mark M Davis, PhD, Ron Levy, MD, Joshua Elias, PhD, Ash A. Alizadeh, MD PhD
Journal: Blood
Blood (2016) 128 (22): 915.
https://doi.org/10.1182/blood.V128.22.915.915
Published: 2016
Journal Articles

Three BTK-Specific Inhibitors, in Contrast to Ibrutinib, Do Not Antagonize Rituximab-Dependent NK-Cell Mediated Cytotoxicity

Narendiran Rajasekaran, PhDMSc, Mohith Sadaram, BS, Jonathan Hebb, MD, Idit Sagiv-Barfi, PhD, Sid Ambulkar, Amanda Rajapaksa, Serena Chang, PhD, Cariad Chester, Erin Waller, Lai Wang, PhD, Brian Lannutti, PhD, Dave Johnson, Ron Levy, MD, Holbrook E Kohrt, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3118.
https://doi.org/10.1182/blood.V124.21.3118.3118
Published: 2014
Journal Articles

Ibrutinib Enhances the Anti-Tumor Immune Response Induced By Intratumoral Injection of a TLR9 Ligand

Idit Sagiv-Barfi, Holbrook Kohrt, MD, Laura Burckhardt, Debra K Czerwinski, Ron Levy, MD
Journal: Blood
Blood (2014) 124 (21): 3121.
https://doi.org/10.1182/blood.V124.21.3121.3121
Published: 2014
Journal Articles

Dose-Escalated, Intratumoral TLR9 Agonist and Low-Dose Radiation Induce Abscopal Effects in Follicular Lymphoma

Holbrook E Kohrt, MD PhD, Jaqueline Chu, MD, Joshua Brody, MD, Debra K Czerwinski, Cariad Chester, Mohith Sadaram, BS, Ranjana Advani, MD, Youn H. Kim, MD, Richard T. Hoppe, MD, Susan J. Knox, MD PhD, Irene Wapnir, MD, Robert J. Tibshirani, PhD, Ron Levy, MD
Journal: Blood
Blood (2014) 124 (21): 3092.
https://doi.org/10.1182/blood.V124.21.3092.3092
Published: 2014
Journal Articles

Obinutuzumab (GA101) Is Less Prone to Antagonism of Immune Effector Function By Ibrutinib Than Rituximab in Vitro and in Vivo

Sylvia Herter, PhD, Idit Sagiv-Barfi, PhD, Cariad Chester, Mohith Sadaram, BS, Jonathan Hebb, MD, Debra K Czerwinski, Narendiran Rajasekaran, PhDMSc, Marina Bacac, PhD, Pablo Umana, PhD, Ron Levy, MD, Christian Klein, PhD, Holbrook E Kohrt, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1765.
https://doi.org/10.1182/blood.V124.21.1765.1765
Published: 2014
Journal Articles

In Situ Vaccination with TLR9 Agonist Combined with Local Radiation In Mycosis Fungoides: Analysis of Phase I/II Study

Youn H. Kim, MD, Dita Gratzinger, MD, PhD, Cameron Harrison, MD, Joshua Brody, MD, Debra Czerwinski, Leon Xing, Anjali Morales, MD, PhD, Weiyun Ai, MD, PhD, Farah Abdulla, MD, Daniel Navi, MD, Robert J. Tibshirani, PhD, Ranjana Advani, MD, Yasodha Natkunam, MD, PhD, Richard T. Hoppe, MD, Ron Levy, MD
Journal: Blood
Blood (2010) 116 (21): 286.
https://doi.org/10.1182/blood.V116.21.286.286
Published: 2010
Journal Articles

Immunomodulation of NK Cells through 4-1BB (CD137) to Improve the Anti-Lymphoma Activity of Rituximab: Antibody-Based Anti-Lymphoma Synergy

Holbrook E Kohrt, MD, Roch Houot, MD/PhD, Matthew J Goldstein, MD, Kipp Weiskopf, MD, Mark Chao, MD, Lieping Chen, MD/PhD, Thomas Tedder, PhD, Ron Levy, MD
Journal: Blood
Blood (2010) 116 (21): 422.
https://doi.org/10.1182/blood.V116.21.422.422
Published: 2010
Journal Articles

Self-Antigen Recognition by the B Cell Receptors of Follicular Lymphoma

Kacey Layn Sachen, BS, Ash A. Alizadeh, MD/PhD, Nicole Kattah, Ph.D., Shoshana Levy, Ron Levy, MD
Journal: Blood
Blood (2010) 116 (21): 4124.
https://doi.org/10.1182/blood.V116.21.4124.4124
Published: 2010